(A–C) Inhibition of tumor formation in athymic mice after Efp siRNA treatment. Eight-week-old female athymic mice were subcutaneously injected with Ishikawa cells (5 × 105 cells) mixed with Matrigel. When the average tumor volume exceeded 150 mm3, 5 μg of siEfp #A or siControl mixed with 4 μL of GeneSilencer, a transfection reagent, was directly injected into the formed tumors twice a week. Representative tumors generated in athymic mice are shown (A). The tumor size was measured every week. Data are presented as means ± s.e. (n = 10). *, P P < 0.01 (B). Tumors were dissected from the mice 7 weeks after siRNA administration and their homogenates were subjected to western blot analysis using antibodies for Efp and 14-3-3σ. β-actin was analyz...
<p>(A) Tumor volumes after administration of sicntr and siNRP-2 liposomes. Nude mice (7 per group) w...
<p>(<b>A</b>) MS17-57 mAb inhibits the growth of MKN45 tumor cell xenografts. Cells (1x10<sup>6</sup...
<p>(A) SDS-PAGE identification of proteins. Lane 1, SEA; lane 2, EGF-SEA. (B) Effect of treatments o...
(A–C) Inhibition of orthotopic tumor formation in athymic mice after Efp siRNA treatment. HEC-1A-luc...
(A) Growth inhibition of Ishikawa cells by Efp siRNAs. Ishikawa cells were transfected with siEfp #A...
<p>MDA-MB-435S cells were implanted in the mammary fat pad of SCID/NOD mice. Two days post-implantat...
<p>Tumor growth kinetics of MCF7 Xenograft treated with EpApt-siEp. Female nude mice (Hsd: Athymic N...
(A) Knockdown efficiency of Efp siRNAs in Ishikawa cells. Cells were transfected with siEfp #A, #B, ...
<p>(<b>A</b>) Schematic drawing of the experimental plan. s.c.: subcutaneous. (<b>B</b>) <i>In vivo<...
<p>(A) Photographs of nude mice and tumors extracted from C9orf86 knockdown and NC groups (MCF-7 and...
<p>1×10<sup>6</sup> cells transfected with control (mice 1–4) or Src+STAT3 siRNAs (mice 5–8) were im...
<p>(A) The GRB7 stably expressing A2780cp cells (Acp-GRB7) were subcutaneously injected into the rig...
<p>A: 1×10<sup>6</sup> A2780 cells were injected into female mouse ovary. After 10 days of post-inje...
<p>Female BALB/c mice bearing AB12 tumors were treated with either vehicle (Control) or DSF-Cu as de...
<p>The tumor growth inhibition analysis in nude mice bearing Bel-7402 tumors after injection of vari...
<p>(A) Tumor volumes after administration of sicntr and siNRP-2 liposomes. Nude mice (7 per group) w...
<p>(<b>A</b>) MS17-57 mAb inhibits the growth of MKN45 tumor cell xenografts. Cells (1x10<sup>6</sup...
<p>(A) SDS-PAGE identification of proteins. Lane 1, SEA; lane 2, EGF-SEA. (B) Effect of treatments o...
(A–C) Inhibition of orthotopic tumor formation in athymic mice after Efp siRNA treatment. HEC-1A-luc...
(A) Growth inhibition of Ishikawa cells by Efp siRNAs. Ishikawa cells were transfected with siEfp #A...
<p>MDA-MB-435S cells were implanted in the mammary fat pad of SCID/NOD mice. Two days post-implantat...
<p>Tumor growth kinetics of MCF7 Xenograft treated with EpApt-siEp. Female nude mice (Hsd: Athymic N...
(A) Knockdown efficiency of Efp siRNAs in Ishikawa cells. Cells were transfected with siEfp #A, #B, ...
<p>(<b>A</b>) Schematic drawing of the experimental plan. s.c.: subcutaneous. (<b>B</b>) <i>In vivo<...
<p>(A) Photographs of nude mice and tumors extracted from C9orf86 knockdown and NC groups (MCF-7 and...
<p>1×10<sup>6</sup> cells transfected with control (mice 1–4) or Src+STAT3 siRNAs (mice 5–8) were im...
<p>(A) The GRB7 stably expressing A2780cp cells (Acp-GRB7) were subcutaneously injected into the rig...
<p>A: 1×10<sup>6</sup> A2780 cells were injected into female mouse ovary. After 10 days of post-inje...
<p>Female BALB/c mice bearing AB12 tumors were treated with either vehicle (Control) or DSF-Cu as de...
<p>The tumor growth inhibition analysis in nude mice bearing Bel-7402 tumors after injection of vari...
<p>(A) Tumor volumes after administration of sicntr and siNRP-2 liposomes. Nude mice (7 per group) w...
<p>(<b>A</b>) MS17-57 mAb inhibits the growth of MKN45 tumor cell xenografts. Cells (1x10<sup>6</sup...
<p>(A) SDS-PAGE identification of proteins. Lane 1, SEA; lane 2, EGF-SEA. (B) Effect of treatments o...